Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADC Therapeutics SA | 1,550,000 | reported | 13 Feb 2026 | tx 7+1,550,000−631,209 |
| Atara Biotherapeutics, Inc. | 16,928 | reported | 10 Jun 2025 | tx 7+401,328 |
| Rafael Holdings, Inc. | 0 | reported | 01 Feb 2022 | tx 2+908,497−908,497 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2026 | TAX_WITHHOLDING | ADC Therapeutics SA | 103,231 | 3.99 USD | |
| 13 Feb 2026 | GRANT_AWARD | ADC Therapeutics SA | 900,000 | 3.99 USD | |
| 06 Dec 2025 | TAX_WITHHOLDING | ADC Therapeutics SA | 233,146 | 3.29 USD | |
| 10 Jun 2025 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 7,828 | 0.00 USD | |
| 06 May 2025 | TAX_WITHHOLDING | ADC Therapeutics SA | 26,758 | 1.29 USD | |
| 13 Feb 2025 | GRANT_AWARD | ADC Therapeutics SA | 650,000 | 1.61 USD | |
| 06 Dec 2024 | TAX_WITHHOLDING | ADC Therapeutics SA | 238,343 | 3.13 USD | |
| 07 May 2024 | SALE | ADC Therapeutics SA | 29,731 | 4.48 USD | |
| 31 Mar 2024 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 150,000 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 57,000 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 79,500 | 0.00 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 20,500 | 0.00 USD | |
| 23 Jun 2022 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 31,500 | 0.00 USD | deriv |
| 01 Feb 2022 | OTHER | Rafael Holdings, Inc. | 908,497 | 0.00 USD | |
| 09 Aug 2021 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 55,000 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | Rafael Holdings, Inc. | 908,497 | 44.70 USD |